Cargando…
Dynamics and Potential Impact of the Immune Response to Chronic Myelogenous Leukemia
Recent mathematical models have been developed to study the dynamics of chronic myelogenous leukemia (CML) under imatinib treatment. None of these models incorporates the anti-leukemia immune response. Recent experimental data show that imatinib treatment may promote the development of anti-leukemia...
Autores principales: | Kim, Peter S., Lee, Peter P., Levy, Doron |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2427197/ https://www.ncbi.nlm.nih.gov/pubmed/18566683 http://dx.doi.org/10.1371/journal.pcbi.1000095 |
Ejemplares similares
-
Chronic myelogenous leukemia in Libya
por: Mehdi, Itrat, et al.
Publicado: (2012) -
Chronic myelogenous leukemia on target
por: Némethová, Veronika, et al.
Publicado: (2018) -
Atypical Presentation of Chronic Myelogenous Leukemia
por: Updyke, Katelyn Mariko, et al.
Publicado: (2017) -
Chronic myelogenous leukemia in ulcerative colitis
por: Katsanos, Konstantinos H., et al.
Publicado: (2011) -
Chronic Myelogenous Leukemia (CML) in the elderly
por: Balducci, Lodovico, et al.
Publicado: (2014)